Jeffrey H Lawson's most recent trade in Humacyte Inc was a trade of 1,194,815 Stock Options (right to buy) done . Disclosure was reported to the exchange on Aug. 26, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Humacyte Inc | Jeffrey H. Lawson | Director, Chief Surgical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 1,194,815 | 1,194,815 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Jeffrey H. Lawson | Director, Chief Surgical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 118,168 | 118,168 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Jeffrey H. Lawson | Director, Chief Surgical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 90,595 | 90,595 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Jeffrey H. Lawson | Director, Chief Surgical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 65,649 | 65,649 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Jeffrey H. Lawson | Director, Chief Surgical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 7,877 | 7,877 | - | - | Common Stock | |
| Humacyte Inc | Jeffrey H. Lawson | Director, Chief Surgical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 1,575 | 1,575 | - | - | Stock Options (right to buy) |